Similar to This
Escape from Fleet Week: Five Blue Angels-free outings in the Bay Area: From Taco Bell Beach to a bay-front preserve, five weekend excursions for people — and ...
sfchronicle.com/totalsf/article/escape-fleet-week-san-francisco-22468826.php
Escape from Fleet Week: Five Blue Angels-free outings in the Bay Area
TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range: The clinical-stage biotech sold about 8.3 million shares at $14 each ...
qz.com/trex-bio-ipo-116-million-autoimmune-100926
TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its ...
Q32 Bio stock soared after its alopecia drug cleared a key clinical bar: The biotech's Phase 2a study of bempikibart showed a 35 ... Show more
Abu Dhabi to trial new cancer treatment in drive to 'revolutionise' chemotherapy: US company BioSapien set to test 3D-printed mesh to combat colorectal cancer
thenationalnews.com/news/uae/2026/06/26/abu-dhabi-to-trial-new-cancer-treatment-in-drive-to-revolutionise-chemotherapy/
Abu Dhabi to trial new cancer treatment in drive to 'revolutionise' ...
LinkedIn user hides AI prompt injection in bio to force recruitment spam to be sent in Olde English prose — bots also manipulated to address user as ‘My Lord’
tomshardware.com/tech-industry/artificial-intelligence/linkedin-recruitment-spam-becomes-olde-english-prose-after-user-hides-ai-prompt-injection-in-bio-bots-also-also-manipulated-to-address-user-as-my-lord
LinkedIn user hides AI prompt injection in bio to force recruitment spam ...
Biotech raises $42 million to run Huntington’s disease trial: Biotech startup, Latus Bio, raised $42 million as it prepares to seek FDA permission to start a ...
statnews.com/2026/05/04/biotech-startup-latus-bio-raises-42-million-run-huntingtons-trial/
Biotech raises $42 million to run Huntington’s disease trial
Gossamer lung disease drug fails late-stage study, but company will still seek FDA approval
statnews.com/2026/02/23/gossamer-drug-fails-lung-disease-study-will-still-seek-fda-approval/
Gossamer lung disease drug fails late-stage study, but company will still ...
A New Concern About Weight Loss Drugs: What if They Work Too Well?: Some patients in a clinical trial of one new drug lost so much weight that they became ...
nytimes.com/2026/02/18/well/weight-loss-drugs-retatrutide.html
A New Concern About Weight Loss Drugs: What if They Work Too Well?
AI Could Reshape Clinical Trials—and the Business of Pharma: AI promised to speed up drug discovery, but the real bottleneck is in clinical trials ...
time.com/7372610/ai-drug-clinical-trials/
AI Could Reshape Clinical Trials—and the Business of Pharma
Dying Skills: Abilities Becoming Obsolete Today: "Writing well. People just don't care."
buzzfeed.com/jenniferadams2/people-are-sharing-the-skills-that-are-becoming-more-and
Dying Skills: Abilities Becoming Obsolete Today
Chinese firm unveils bone adhesive that repairs fractures within minutes: The product, referred to as “Bone 02 Bone Cement”, is intended to improve surgical ...
premiumtimesng.com/health/health-news/824552-chinese-firm-unveils-bone-adhesive-that-repairs-fractures-within-minutes.html
Chinese firm unveils bone adhesive that repairs fractures within minutes